Description

A CA-125 blood test may be used to monitor treatment for ovarian cancer. If CA-125 levels go down, it usually means the treatment is working. Check to see if cancer has come back after successful treatment. Screen women who are at high risk for ovarian cancer.

• Serum

CA-125 is recommended, together with transvaginal ultrasound, for early detection of ovarian cancer in women with hereditary syndromes because early intervention may be beneficial in these women. It is also recommended as an adjunct in distinguishing benign from malignant suspicious pelvic masses, particularly in postmenopausal women.